Amendment #165 to H4617

Pharma Amendment

Mr. Ryan of Boston moves to amend the bill By striking out, in section 16, the following sentence:- No pharmaceutical manufacturing company identified as a witness under this section, or any testimony by any such company, shall be subject to the provisions of section 17 of chapter 12C.

By inserting, in line 597, after the word “manager”, the following words:- pharmaceutical manufacturing company;

By striking out, in lines 598 and 599, the words “sections 8, 9, 10 and 10B” and inserting in place thereof the following:- sections 8, 9, 10, 10A and 10B;

By inserting, in line 606, after the word “manager”, the following words:- pharmaceutical manufacturing company; and

By inserting, after section 42, the following 3 sections:-

SECTION 42A. Said section 17 of said chapter 12C, as so appearing, is hereby amended by striking out, in lines 2 and 3, the words “sections 8, 9, and 10” and inserting in place thereof the following:- sections 8, 9, 10, 10A and 10B.

SECTION 42B. Said section 17 of said chapter 12C, as so appearing, is hereby amended by striking out, in lines 4 and 5, the words “or payer” and inserting in place thereof the following:- , payer, pharmaceutical manufacturing company or pharmacy benefit manager.

SECTION 42C. Said section 17 of said chapter 12C, as so appearing, is hereby amended by striking out, in line 12, the words “or payer” and inserting in place thereof the following:- , payer, pharmaceutical manufacturing company or pharmacy benefit manager.